Applied DNA Sciences is a diagnostics & research business based in the US. Applied DNA Sciences shares (APDN) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $0.17 – an increase of 1.85% over the previous week. Applied DNA Sciences employs 52 staff and has a trailing 12-month revenue of around $3.4 million.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
| Latest market close | $0.17 |
|---|---|
| 52-week range | $0.15 - $22.80 |
| 50-day moving average | $0.60 |
| 200-day moving average | $3.62 |
| Wall St. target price | $1.50 |
| PE ratio | N/A |
| Dividend yield | N/A |
| Earnings per share (TTM) | $-7.50 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $0.1658 from 2024-11-19
| 1 week (2024-11-15) | 2.35% |
|---|---|
| 1 month (2024-10-22) | -51.09% |
| 3 months (2024-08-22) | -90.94% |
| 6 months (2024-05-22) | -91.49% |
| 1 year (2023-11-22) | -80.70% |
|---|---|
| 2 years (2022-11-22) | -99.42% |
| 3 years (2021-11-22) | 95.6 |
| 5 years (2019-11-22) | 81.2 |
| Revenue TTM | $3.4 million |
|---|---|
| Gross profit TTM | $5.1 million |
| Return on assets TTM | -57.44% |
| Return on equity TTM | -76.08% |
| Profit margin | -214.48% |
| Book value | $1.20 |
| Market Capitalization | $8.8 million |
TTM: trailing 12 months
We're not expecting Applied DNA Sciences to pay a dividend over the next 12 months.
Applied DNA Sciences's shares were split on a 1:20 basis on 24 April 2024 . So if you had owned 20 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Applied DNA Sciences shares – just the quantity. However, indirectly, the new 1900% higher share price could have impacted the market appetite for Applied DNA Sciences shares which in turn could have impacted Applied DNA Sciences's share price.
Over the last 12 months, Applied DNA Sciences's shares have ranged in value from as little as $0.1462 up to $22.8. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Applied DNA Sciences's is 0.452. This would suggest that Applied DNA Sciences's shares are less volatile than average (for this exchange).
Applied DNA Sciences, Inc. , a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. It operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR) for production and detection of DNA and RNA; and MDx test kits and related supplies, as well as Isotopic analysis testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, nutraceuticals, and other products; SigNify portable DNA readers and SigNify consumable reagent test kits; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2024 according to Finder’s comprehensive review.
The best platforms to use for automatic investing include Wealthfront, SoFi, Schwab, Vanguard, Titan, Acorns and more. See our full list here.
We’ve rounded up stats on some of the most popular graphene stocks, along with information on how they compare and how to invest.
5 Betterment robo-advisor alternatives to consider when building your portfolio.
What you need to know about investing in the leading indicator for the overall US stock market.
How do you gift stocks to loved ones? Learn the ins and outs of finding the right investments for them.
Check out the best-performing ETFs so far in 2024.
Acorns is a financial service that rounds up your purchases and turns the extra change into investments.